ArticleOncotarget2017

ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.

Anna-Lena Geißler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.